Natera (NTRA) Competitors

Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment, community ranking and analyst recommendations.

Do analysts rate FMS or NTRA?

Fresenius Medical Care presently has a consensus price target of $25.30, indicating a potential upside of 9.55%. Natera has a consensus price target of $170.94, indicating a potential upside of 6.47%. Given Fresenius Medical Care's higher possible upside, analysts clearly believe Fresenius Medical Care is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community believe in FMS or NTRA?

Natera received 61 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 69.04% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Fresenius Medical Care	Outperform Votes 423 54.72%	Underperform Votes 350 45.28%
Natera	Outperform Votes 484 69.04%	Underperform Votes 217 30.96%

Does the media prefer FMS or NTRA?

In the previous week, Natera had 10 more articles in the media than Fresenius Medical Care. MarketBeat recorded 13 mentions for Natera and 3 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.56 beat Natera's score of 1.27 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Natera	10 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is FMS or NTRA more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care	3.43%	6.04%	2.69%
Natera	-14.01%	-26.23%	-14.27%

Which has better valuation and earnings, FMS or NTRA?

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care	$21.05B	0.64	$540.07M	$1.21	19.09
Natera	$1.08B	19.58	-$434.80M	-$1.76	-91.22

Do insiders and institutionals hold more shares of FMS or NTRA?

8.4% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has more risk & volatility, FMS or NTRA?

Fresenius Medical Care has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500.

Summary

Fresenius Medical Care and Natera tied by winning 9 of the 18 factors compared between the two stocks.